These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 30138161)
61. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. Cammarota G; Ianiro G; Gasbarrini A J Clin Gastroenterol; 2014 Sep; 48(8):693-702. PubMed ID: 24440934 [TBL] [Abstract][Full Text] [Related]
62. Proton pump inhibitor in upper gastrointestinal fecal microbiota transplant: A systematic review and analysis. Hong AS; Yu WY; Hong JM; Cross CL; Azab M; Ohning G; Jayaraj M J Gastroenterol Hepatol; 2020 Jun; 35(6):932-940. PubMed ID: 31830335 [TBL] [Abstract][Full Text] [Related]
63. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection. Kelly BJ; Tebas P Chest; 2018 Jan; 153(1):266-277. PubMed ID: 28923757 [TBL] [Abstract][Full Text] [Related]
65. Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome. Walia R; Garg S; Song Y; Girotra M; Cuffari C; Fricke WF; Dutta SK J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):565-70. PubMed ID: 25023578 [TBL] [Abstract][Full Text] [Related]
67. Review of the emerging treatment of Clostridium difficile infection with fecal microbiota transplantation and insights into future challenges. Kassam Z; Lee CH; Hunt RH Clin Lab Med; 2014 Dec; 34(4):787-98. PubMed ID: 25439277 [TBL] [Abstract][Full Text] [Related]
68. The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent Peri R; Aguilar RC; Tüffers K; Erhardt A; Link A; Ehlermann P; Angeli W; Frank T; Storr M; Glück T; Sturm A; Rosien U; Tacke F; Bachmann O; Solbach P; Stallmach A; Goeser F; Vehreschild MJ; United European Gastroenterol J; 2019 Jun; 7(5):716-722. PubMed ID: 31210950 [TBL] [Abstract][Full Text] [Related]
69. Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection. Hvas CL; Dahl Jørgensen SM; Jørgensen SP; Storgaard M; Lemming L; Hansen MM; Erikstrup C; Dahlerup JF Gastroenterology; 2019 Apr; 156(5):1324-1332.e3. PubMed ID: 30610862 [TBL] [Abstract][Full Text] [Related]
70. Fecal microbiota transplantation for treatment of patients with recurrent Voth E; Khanna S Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848 [TBL] [Abstract][Full Text] [Related]
73. Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data. Costello SP; Conlon MA; Vuaran MS; Roberts-Thomson IC; Andrews JM Aliment Pharmacol Ther; 2015 Oct; 42(8):1011-8. PubMed ID: 26264455 [TBL] [Abstract][Full Text] [Related]
74. [Efficacy analysis of fecal microbiota transplantation in the treatment of 406 cases with gastrointestinal disorders]. Li N; Tian H; Ma C; Ding C; Ge X; Gu L; Zhang X; Yang B; Hua Y; Zhu Y; Zhou Y Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):40-46. PubMed ID: 28105618 [TBL] [Abstract][Full Text] [Related]
75. Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota. Staley C; Vaughn BP; Graiziger CT; Singroy S; Hamilton MJ; Yao D; Chen C; Khoruts A; Sadowsky MJ Gut Microbes; 2017 May; 8(3):276-288. PubMed ID: 28282270 [TBL] [Abstract][Full Text] [Related]
76. Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials. Moayyedi P; Yuan Y; Baharith H; Ford AC Med J Aust; 2017 Aug; 207(4):166-172. PubMed ID: 28814204 [TBL] [Abstract][Full Text] [Related]
77. Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia. Merlo G; Graves N; Brain D; Connelly LB J Gastroenterol Hepatol; 2016 Dec; 31(12):1927-1932. PubMed ID: 27043242 [TBL] [Abstract][Full Text] [Related]
78. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians. Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687 [TBL] [Abstract][Full Text] [Related]
79. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection. Costello SP; Tucker EC; La Brooy J; Schoeman MN; Andrews JM Clin Infect Dis; 2016 Apr; 62(7):908-14. PubMed ID: 26628567 [TBL] [Abstract][Full Text] [Related]
80. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]